Lipid accumulation in the liver leads to impaired insulin signaling and insulin resistance, which are key symptoms of NAFLD progression (Marchesini et al., 1999; Samuel & Shulman, 2012). The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.